| Raymond Stevens, Ph.D. | Chief Executive Officer and Director | FY2025 | |
| Jun Yoon | Chief Financial Officer | FY2025 | |
| Blai Coll, M.D., Ph.D. | Chief Medical Officer | FY2025 | |
| Xichen Lin, Ph.D. | Chief Scientific Officer | FY2025 | |
| Yingli Ma, Ph.D. | Chief Technology Officer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.